The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Johanna Klughammer, Barbara Kiesel, Thomas Roetzer-Pejrimovsky, +51

Nature Medicine

Neuro-oncologyChromatinDna Methylation LandscapeGlioblastoma Disease ProgressionTumor Heterogeneity +11

New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors

Nicole Golob‐Schwarzl, Stefanie Krassnig, Anna M. Toeglhofer, +8

European Journal of Cancer

Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6

Nicole Golob‐Schwarzl, Caroline Schweiger, Carina Koller, +23

Oncotarget

Tumor BiologyOncologyGastrointestinal OncologyMedicineRectum Carcinoma +13

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space

Johanna Klughammer, Barbara Kiesel, Thomas Roetzer, +48

EngineeringEpigenetic ChangeGeneticsDna MethylationMolecular Biology +20

Influence of eukaryotic translation initiation factor 6 on non–small cell lung cancer development and progression

Nadine Gantenbein, Eva Bernhart, Ines Anders, +25

European Journal of Cancer

Effects of concentration and vendor specific composition of formalin on postmortem MRI of the human brain

Christoph Birkl, Martin Soellradl, Anna M. Toeglhofer, +9

Magnetic Resonance in Medicine

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype

Nicole Golob‐Schwarzl, Kira Bettermann, Anita K. Mehta, +25

Translational Oncology

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures

Joshua Alcaniz, Lars Winkler, Mathias Dahlmann, +12

Frontiers in Oncology

Chemoprevention StrategyGbm ModelsHigh-grade GliomasGliomaTumor Biology +19

A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy

Stefanie Krassnig, Christina Wohlrab, Nicole Golob‐Schwarzl, +15

Cancers

Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival

Florian Kleinegger, Eva Hofer, Christina Wodlej, +19

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

ImmunologyPathologyCholangiopathiesIl-6 Classic SignalingCancer Biology +15